India experienced a decrease in the number of COVID-19 cases in May 2021. However, no data is available to support the claim that this is causally associated with the recommendation to use ivermectin. The slow down of the disease spreading began before India released official recommendations to use that drug. In spite of several clinical studies, no reliable evidence is available to suggest that hydroxychloroquine or ivermectin are effective against COVID-19. At the moment, international health agencies and scientific societies discourage using these drugs to treat COVID-19, except in clinical trials designed to assess their efficacy.